Joseph Tam

6.5k total citations · 1 hit paper
104 papers, 4.8k citations indexed

About

Joseph Tam is a scholar working on Pharmacology, Surgery and Molecular Biology. According to data from OpenAlex, Joseph Tam has authored 104 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Pharmacology, 32 papers in Surgery and 27 papers in Molecular Biology. Recurrent topics in Joseph Tam's work include Cannabis and Cannabinoid Research (53 papers), Pancreatic function and diabetes (28 papers) and Diet, Metabolism, and Disease (23 papers). Joseph Tam is often cited by papers focused on Cannabis and Cannabinoid Research (53 papers), Pancreatic function and diabetes (28 papers) and Diet, Metabolism, and Disease (23 papers). Joseph Tam collaborates with scholars based in Israel, United States and Germany. Joseph Tam's co-authors include George Kunos, Grzegorz Godlewski, Reşat Çınar, Bani Mukhopadhyay, Itai Bab, Tony Jourdan, Esther Shohami, Orr Ofek, Gergő Szanda and Jie Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Joseph Tam

99 papers receiving 4.7k citations

Hit Papers

Activation of the Nlrp3 inflammasome in infiltrating macr... 2013 2026 2017 2021 2013 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph Tam Israel 34 2.6k 1.2k 1.1k 983 957 104 4.8k
Reşat Çınar United States 35 1.8k 0.7× 894 0.7× 758 0.7× 538 0.5× 702 0.7× 82 3.5k
Heather B. Bradshaw United States 43 2.9k 1.1× 920 0.8× 602 0.5× 889 0.9× 486 0.5× 120 5.1k
Douglas Osei‐Hyiaman United States 32 3.8k 1.5× 731 0.6× 1.9k 1.7× 1.3k 1.3× 1.1k 1.1× 40 5.6k
Valeria Gasperi Italy 31 1.7k 0.7× 647 0.5× 375 0.3× 652 0.7× 463 0.5× 69 3.4k
Cristoforo Silvestri Canada 29 1.3k 0.5× 1.2k 1.0× 595 0.5× 725 0.7× 337 0.4× 68 3.0k
Michael L. Mathai Australia 36 519 0.2× 1.1k 0.9× 680 0.6× 1.0k 1.0× 482 0.5× 147 4.5k
Maria José Campagnole‐Santos Brazil 40 1.2k 0.5× 2.4k 2.0× 2.6k 2.3× 771 0.8× 976 1.0× 141 7.3k
Christoffer Clemmensen Denmark 32 584 0.2× 1.6k 1.4× 1.5k 1.3× 1.9k 2.0× 1.2k 1.2× 88 5.2k
Valerio Chiurchiù Italy 33 1.2k 0.5× 1.1k 0.9× 222 0.2× 600 0.6× 406 0.4× 71 3.6k
K Varga United States 28 2.3k 0.9× 537 0.4× 443 0.4× 494 0.5× 288 0.3× 50 3.9k

Countries citing papers authored by Joseph Tam

Since Specialization
Citations

This map shows the geographic impact of Joseph Tam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Tam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Tam more than expected).

Fields of papers citing papers by Joseph Tam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Tam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Tam. The network helps show where Joseph Tam may publish in the future.

Co-authorship network of co-authors of Joseph Tam

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Tam. A scholar is included among the top collaborators of Joseph Tam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Tam. Joseph Tam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Madrer, Nimrod, Ofir Israeli, Liad Hinden, et al.. (2025). 5′LysTTT tRNA fragments support survival of botulinum-intoxicated neurons by blocking ferroptosis. 1–17. 1 indexed citations
2.
Tam, Joseph, et al.. (2025). Botulinum Neurotoxins: History, Mechanism, and Applications. A Narrative Review. Journal of Neurochemistry. 169(8). e70187–e70187. 3 indexed citations
3.
Murik, Omer, Varda Gross‐Tsur, David A. Zeevi, et al.. (2025). Markedly Low Prevalence of Fatty Liver Despite Obesity in Prader–Willi Syndrome: A Search for Protective Genetic Markers. Journal of Clinical and Experimental Hepatology. 16(1). 103155–103155.
4.
Gandy, J.C., et al.. (2024). Lipolysis pathways modulate lipid mediator release and endocannabinoid system signaling in dairy cows’ adipocytes. Journal of Animal Science and Biotechnology. 15(1). 9 indexed citations
5.
Sweetat, Sahar, Saja Baraghithy, Hava Glickstein, et al.. (2024). The Autophagic Activator GHF-201 Can Alleviate Pathology in a Mouse Model and in Patient Fibroblasts of Type III Glycogenosis. Biomolecules. 14(8). 893–893. 1 indexed citations
6.
Permyakova, Anna, Liad Hinden, Saja Baraghithy, et al.. (2024). Renal Mitochondrial ATP Transporter Ablation Ameliorates Obesity-Induced CKD. Journal of the American Society of Nephrology. 35(3). 281–298. 9 indexed citations
7.
Winek, Katarzyna, Nimrod Madrer, Estelle R. Bennett, et al.. (2023). Lysine tRNA fragments and miR-194-5p co-regulate hepatic steatosis via β-Klotho and perilipin 2. Molecular Metabolism. 79. 101856–101856. 5 indexed citations
8.
Permyakova, Anna, et al.. (2023). Renal Endocannabinoid Dysregulation in Obesity-Induced Chronic Kidney Disease in Humans. International Journal of Molecular Sciences. 24(17). 13636–13636. 7 indexed citations
9.
Hinden, Liad, et al.. (2023). Systemic Changes in Endocannabinoids and Endocannabinoid-like Molecules in Response to Partial Nephrectomy-Induced Ischemia in Humans. International Journal of Molecular Sciences. 24(4). 4216–4216. 4 indexed citations
10.
Hinden, Liad, et al.. (2022). Peripheral Cannabinoid-1 Receptor Blockade Ameliorates Cystitis Severity. Cannabis and Cannabinoid Research. 8(4). 623–633. 2 indexed citations
11.
Gurt, Irina, et al.. (2022). Hepatic adropin is regulated by estrogen and contributes to adverse metabolic phenotypes in ovariectomized mice. Molecular Metabolism. 60. 101482–101482. 12 indexed citations
12.
Permyakova, Anna, et al.. (2020). A Novel Indoline Derivative Ameliorates Diabesity-Induced Chronic Kidney Disease by Reducing Metabolic Abnormalities. Frontiers in Endocrinology. 11. 91–91. 8 indexed citations
13.
Abu‐Remaileh, Muhannad, et al.. (2019). WWOX somatic ablation in skeletal muscles alters glucose metabolism. Molecular Metabolism. 22. 132–140. 24 indexed citations
14.
Udi, Shiran, Liad Hinden, Adi Drori, et al.. (2019). Dual inhibition of cannabinoid CB1 receptor and inducible NOS attenuates obesity‐induced chronic kidney disease. British Journal of Pharmacology. 177(1). 110–127. 52 indexed citations
15.
Hanin, Geula, Nadav Yayon, Estelle R. Bennett, et al.. (2017). miRNA-132 induces hepatic steatosis and hyperlipidaemia by synergistic multitarget suppression. Gut. 67(6). 1124–1134. 105 indexed citations
16.
Tam, Joseph, Ben C. F. Choi, & Zhenhui Jiang. (2015). The Effect of Online Privacy Information on Privacy Evaluations in Using Mobile Fitness Applications. Journal of the Association for Information Systems. 147. 3 indexed citations
17.
Tam, Joseph. (2015). The emerging role of the endocannabinoid system in the pathogenesis and treatment of kidney diseases. Journal of Basic and Clinical Physiology and Pharmacology. 27(3). 267–276. 58 indexed citations
18.
Çınar, Reşat, Grzegorz Godlewski, Jie Liu, et al.. (2013). Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasing de novo synthesis of long-chain ceramides. Hepatology. 59(1). 143–153. 144 indexed citations
19.
Liu, Jie, Liang Zhou, Keming Xiong, et al.. (2012). Hepatic Cannabinoid Receptor-1 Mediates Diet-Induced Insulin Resistance via Inhibition of Insulin Signaling and Clearance in Mice. Gastroenterology. 142(5). 1218–1228.e1. 145 indexed citations
20.
Silverman, Marni N., Partha Mukhopadhyay, Elena Belyavskaya, et al.. (2012). Glucocorticoid receptor dimerization is required for proper recovery of LPS-induced inflammation, sickness behavior and metabolism in mice. Molecular Psychiatry. 18(9). 1006–1017. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026